Background

The University of Nottingham and Tioga Ltd secured Innovate UK grant funding to assemble a joint clinical, design and engineering project team to integrate the an optical sensor into a single use newborn hat and to undertake clinical studies on newborn babies. The hat will enable clinicians to resuscitate ‘hands-free’, reduce delays and errors, and so improve resuscitation outcomes, giving newborn babies the best start to life.

Background

The East Midlands Academic Health Science Network (EMAHSN) is working with commissioners and acute NHS trusts to roll out the use of Silhouette® 3D cameras to assess diabetic foot ulcers. Initially they have been working in Southern Derbyshire with Entec Health, the UK distributor of Silhouette® (ARANZ Medical), to assess and treat diabetic foot ulcers in the community rather than at hospital.

Background

The client­ is a leading company who designs, develops and manufactures aerosol drug delivery and associated lung health devices. They sought CHEATAs advice and knowledge to help contribute to the Value Proposition of one of their CE marked products that is currently on the market and to advise on engagement with the NICE MTEP committee for potential inclusion into their guidelines.

Background

Smartlife Inc Ltd are a Manchester-based company that specialise in smart garment technology.  They have developed innovative, patented textile sensors, electronics and firmware that are capable of detecting the body’s biophysical signals, and delivering actionable insight to users via mobile apps. In order to move their technology into the healthcare sector, they secured EU funding through the H2020 scheme

Background

Platelet Solutions Ltd is a spin-out company of the University of Nottingham formed in 2011, and is the outcome of many years of research and experience in the Thrombosis and Haemostasis Group. The company focuses on the provision of products and services for platelet function testing. Platelet function testing is required for diagnosis of abnormal bleeding and to monitor platelet function in those who are at-risk of vascular events such as heart attack or stroke. 

Background

The client­ is a global manufacturer of personal healthcare products that have a number of CE marked medical devices and accessories on the market. One of their products, launched in 2003, had acquired a body of evidence (both published and unpublished) from clinicians and patients, and a review of this data suggested that this product could be suitable for inclusion into NICE guidelines.